Patterson (PDCO) said late Tuesday that the 40-day "go-shop" period under the terms of its go-private deal with health care investment firm Patient Square Capital has expired.
The dental and animal health distributor said it did not receive any alternative acquisition proposals from any third party during the period.
Patient Square recently agreed to acquire Patterson for $31.35 per share in an all-cash deal valued at roughly $4.1 billion. That deal is expected to close in April, subject to approval by Patterson shareholders and US antitrust clearance, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.